InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: centsability4me post# 27057

Monday, 05/09/2016 11:39:23 AM

Monday, May 09, 2016 11:39:23 AM

Post# of 118384
Not only is Harry Lander now CEO of MolecuVax, but Thomas Ichim is on Scientific Advisory Board and they are beginning clinical trials at the same center in Tijuana as for HemaX.

Furthermore, T. Ichim speaks about his research on the BORIS method of killing cancer cells which MolecuVax is based on (I thought T. Ichim's BORIS IP belonged to RGBP? Is MolecuVax based on T. Ichim's IP bought by RGBP, but changed slightly, or is this being done in MX because the patent is only valid in US? I have no idea, but this musical chairs of scientists and Board Members and now President being CEO of another competing company simultaneously just doesn't look good for us.

check this link MolecuVax trials